{
  "pmcid": "9577542",
  "sha256": "129714b24619777c39ed324bf114e931ce872bfa790c2986e03d12d1375a0f17",
  "timestamp_utc": "2025-11-09T16:21:51.349239+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 7.937834612105714,
    "reading_ease": 57.89938618925834,
    "word_count": 255
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "This trial aimed to assess disease recurrence and survival rates between patients with locally advanced rectal adenocarcinoma (LARC) who underwent total mesorectal excision (TME) after a waiting interval of 8 weeks or less (classic interval; CI) versus more than 8 weeks (long interval; LI) following preoperative CRT."
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "This was a phase III, single-centre, randomized clinical trial."
      },
      "Participants": {
        "score": 2,
        "evidence": "Patients with LARC situated within 12 cm of the anal verge (T3–T4 or N+ disease) were randomized to undergo TME within or after 8 weeks after CRT."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Patients with LARC situated within 12 cm of the anal verge (T3–T4 or N+ disease) were randomized to undergo TME within or after 8 weeks after CRT."
      },
      "Objective": {
        "score": 1,
        "evidence": "This trial aimed to assess disease recurrence and survival rates between patients with locally advanced rectal adenocarcinoma (LARC) who underwent total mesorectal excision (TME) after a waiting interval of 8 weeks or less (classic interval; CI) versus more than 8 weeks (long interval; LI) following preoperative CRT."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The cumulative incidence of locoregional recurrence at 5 years was 10.1 per cent in the CI group and 6.9 per cent in the LI group ( P = 0.143)."
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "Patients with LARC situated within 12 cm of the anal verge (T3–T4 or N+ disease) were randomized to undergo TME within or after 8 weeks after CRT."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "Between January 2006 and January 2017, 350 patients were randomized, 175 to each group."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Among the 322 included patients (CI, 159; LI, 163)"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The cumulative incidence of distant metastasis at 5 years was 30.8 per cent in the CI group and 18.6 per cent in the LI group (sub-HR = 1.78; 95 per cent c.i. 1.14 to 2.78, P = 0.010)."
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Registration number: NCT03287843 ( http://www.clinicaltrials.gov )."
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 18,
    "max_score": 25
  }
}